Article Details

CTI BioPharma (NASDAQ:CTIC) Downgraded by StockNews.com to “Sell” - ETF Daily News

Retrieved on: 2022-11-19 14:45:22

Tags for this article:

Click the tags to see associated articles and topics

CTI BioPharma (NASDAQ:CTIC) Downgraded by StockNews.com to “Sell” - ETF Daily News. View article details on HISWAI: https://www.etfdailynews.com/2022/11/19/cti-biopharma-nasdaqctic-downgraded-by-stocknews-com-to-sell/

Excerpt

Jefferies Financial Group began coverage on shares of CTI BioPharma in a report on Thursday, September 1st. They issued a “buy” rating and a $13.00 ...

Article found on: www.etfdailynews.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up